Thursday, November 15, 2018

EDGC to Launch Liquid Biopsy Screening Service, Technology for Early Detection of Cancers, This...

Liquid biopsy drawing attention for preventing the recurrence of cancer and allowing for early detection of cancers EDGC develops the most advanced lipuid biopsy technologyEONE-DIAGNOMICS Genome Center (EDGC), a global company in genetic analysis, has announced the...

AIVITA Biomedical Attains Japanese PMDA Milestone for ROOT OF CANCER Technology

Manufacturing, quality and safety data deemed acceptable by Japanese regulatory agency in AIVITA's effort to commercialize ROOT OF CANCER technologyAIVITA Biomedical announced today the successful completion of the manufacturing quality consultation and clinical safety...

Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets

Company to Continue Operating Business and Serving Customers As UsualAralez Pharmaceuticals Inc. announced today that it intends to enter into purchase agreements with two separate stalking-horse purchasers to sell its main operating businesses:  an...

MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia

Partners with Leading Australian Healthcare Products and Biological SupplierMiMedx Group, Inc., a leading developer and marketer of regenerative and therapeutic biologics, today announced that it received regulatory approval from the Therapeutics Goods Administration (TGA)...

Autologous Stem Cell Therapy May Hold Key to Regeneration

USRM Chief Science Officer's Live Webinar Adds Voice to DebateU.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the...

Lilly Announces Agreement To Acquire ARMO BioSciences

.6 billion transaction will bolster Lilly's clinical portfolio with ARMO's lead immuno-oncology asset, pegilodecakin, which is being studied in multiple tumor typesEli Lilly and Company and ARMO BioSciences, Inc. today announced a definitive agreement...

Alcami Announces Industry-Leading Analytical Testing Turnaround Time

Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announces the advancement of the drug development process with the company's new, dramatically-reduced analytical testing turnaround...

Embrace® Active Scar Defense And Serena Williams Team Up To Talk About Motherhood, Healing...

Neodyne Biosciences, Inc. today announced they are partnering with professional tennis champion Serena Williams to raise awareness for its embrace® Active Scar Defense, an FDA cleared scar therapy system designed to prevent the formation of scar tissue...

AdvoCare International Announces the Promotion of Brett Blake as New CEO

AdvoCare International, L.P. today announced the promotion of Brett Blake to Chief Executive Officer, replacing industry-veteran Brian Connolly who served as interim-CEO during the extensive executive search. Connolly will continue to work closely with Brett serving as...

The Menarini Group Announced Marketing Authorization Application for Delafloxacin

The Menarini Group announced today that on March 6th 2017 it submitted a Marketing Authorization Application for delafloxacin at the European Medicines Agency (EMA) under the trade name Quofenix. The proposed indication for delafloxacin in Europe is the...

Connect with us

4,530FansLike
1,007FollowersFollow
12,053FollowersFollow

Popular Posts